secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2025-05-27T23:59:59+00:00
Accession:  0001558370-25-008145
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Capricor stockholders approve 2025 Equity Incentive Plan (3.5M shares plus 5% annual increase)
--------------------------------------------------------------------------------

- Stockholders approved 2025 Equity Incentive Plan (3.5M shares reserved) with ~54% of votes cast in favor (9.7M FOR, 8.2M AGAINST).
- Plan includes annual evergreen increase of 5% of outstanding shares from 2026 through 2035.
- Rose, Snyder & Jacobs LLP ratified as independent auditor for FY2025.
- Say-on-pay advisory vote passed with ~92% in favor (16.4M FOR, 1.5M AGAINST).
- 30.55M shares present (66.9% of outstanding) at annual meeting on May 22, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837025008145/0001558370-25-008145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837025008145/capr-20250522x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer